These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 13655031)
1. A chemical and pharmacological investigation of Piper methysticum Forst. KLOHS MW; KELLER F; WILLIAMS RE; TOEKES MI; CRONHEIM GE J Med Pharm Chem; 1959 Feb; 1(1):95-103. PubMed ID: 13655031 [No Abstract] [Full Text] [Related]
2. [Pharmacology of the active principles of kavaroot (Piper methysticum Forst)]. MEYER HJ Arch Int Pharmacodyn Ther; 1962 Aug; 138():505-36. PubMed ID: 13935274 [No Abstract] [Full Text] [Related]
3. [A drug from Polynesia with central nervous activity: Piper methysticum Forst ("kawa-kawa")]. REALDON E Gazz Med Ital; 1960 Jun; 119():231-3. PubMed ID: 14436715 [No Abstract] [Full Text] [Related]
4. Quantitative elimination of Flavokavines A and B from Kava Kava (Piper methysticum G. Forst) by isoelectric focused adsorptive bubble separation. Backleh M; Ekici P; Leupold G; Parlar H Naturwissenschaften; 2003 Aug; 90(8):366-9. PubMed ID: 12955226 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava). Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328 [TBL] [Abstract][Full Text] [Related]
6. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro. Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion. Zou L; Harkey MR; Henderson GL Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622 [TBL] [Abstract][Full Text] [Related]
8. Analysis of plant extracts by NIRS: simultaneous determination of kavapyrones and water in dry extracts of Piper methysticum Forst. Gaub M; Roeseler Ch; Roos G; Kovar KA J Pharm Biomed Anal; 2004 Nov; 36(4):859-64. PubMed ID: 15533680 [TBL] [Abstract][Full Text] [Related]
9. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Weiss J; Sauer A; Frank A; Unger M Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732 [TBL] [Abstract][Full Text] [Related]
10. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444 [TBL] [Abstract][Full Text] [Related]
11. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract. Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149 [TBL] [Abstract][Full Text] [Related]
12. Kava Hepatotoxicity: Are we any closer to the truth? Anke J; Ramzan I Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493 [TBL] [Abstract][Full Text] [Related]
13. Kava: an overview. Singh YN J Ethnopharmacol; 1992 Aug; 37(1):13-45. PubMed ID: 1453702 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). Anke J; Ramzan I J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747 [TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography-coordination ion spray-mass spectrometry (HPLC-CIS/MS): a new tool for the analysis of non-polar compound classes in plant extracts using the example of Piper methysticum Forst. Gaub M; von Brocke A; Roos G; Kovar KA Phytochem Anal; 2004; 15(5):300-5. PubMed ID: 15508834 [TBL] [Abstract][Full Text] [Related]